Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy

NCT ID: NCT01809119

Last Updated: 2018-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

242 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Partial nephrectomy is considered the standard treatment for renal tumors smaller than 7 cm. With the evolution of image diagnostic tools and dissemination of its use, smaller tumors are being commonly diagnosed and treated. The partial open nephrectomy is still considered the gold standard technique for nephron sparing surgery, especially when the surgeon is not experienced with the minimally invasive surgery. In the last 15 years, uncountable minimally invasive techniques were developed, including the laparoscopic partial nephrectomy. The objective of this study is compare the partial laparoscopic nephrectomy to open partial nephrectomy in terms of perioperative, oncologic and functional outcomes. A balanced randomized prospective trial will be conducted. One group of patients will be submitted to to open partial nephrectomy while the other group of patients will be submitted to laparoscopic partial nephrectomy. A randomized prospective trial comparing the two techniques is necessary to determine the differences in outcomes between them and if the laparoscopic partial nephrectomy can be performed without harms to the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laparoscopic Partial Nephrectomy

Patients with kidney neoplasms submitted to laparoscopic partial nephrectomy

Group Type EXPERIMENTAL

Partial nephrectomy

Intervention Type PROCEDURE

Open Partial Nephrectomy

Patients with kidney neoplasms submitted to open partial nephrectomy

Group Type ACTIVE_COMPARATOR

Partial nephrectomy

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partial nephrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with renal tumor cT1N0M0; (\<7 cm)
* Normal renal function (serum creatinine \<1.2 and glomerular filtration rate\> 60mL/min/1.73m2)
* Tumor only

Exclusion Criteria

* Functional or anatomical solitary kidney
* Horseshoe kidney, ectopic or malformed
* Clinical contraindication to surgery
* Contraindication to laparoscopic surgery
* Association with other renal pathologies
* Evidence of lymph node or systemic disease in preoperative staging
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

University of Sao Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marcos Francisco Dall'Oglio

M.D. Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcos F Dall'Oglio, M.D., Associate Professor

Role: STUDY_DIRECTOR

Cancer Institute of the State of São Paulo - University of Sao Paulo

Giuliano B Guglielmetti, Doctor

Role: PRINCIPAL_INVESTIGATOR

Cancer Institute of the State of São Paulo - University of Sao Paulo

Alexandre C Sant'Anna, Doctor

Role: STUDY_CHAIR

Cancer Institute of the State of São Paulo - University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cancer Institute of the State of São Paulo

São Paulo, , Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sanarelly P Adonias, Study Coordinator

Role: CONTACT

+ 55 11 3893-2528

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanarelly P Adonias, Study Coordinator

Role: primary

+55 11 3893-2528

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UROUSP - 005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.